BLCO Stock — Price, Charts & Analysis

Bausch + Lomb Corporation (BLCO) has no trailing P/E shown and a forward P/E of 15.83x. This places BLCO in a moderate earnings multiple territory based on the valuation data currently available on Worldtickers.

BLCO trades with 15.83x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether BLCO looks overvalued or undervalued.

BLCO's P/E of 15.83x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

BLCO's trailing EPS is -$0.48 and forward EPS is $1.09.

EPS, or earnings per share, shows how much profit Bausch + Lomb Corporation generated for each share. BLCO's trailing EPS is -$0.48, and investors usually prefer EPS that is positive and growing over time.

Bausch + Lomb Corporation has a market cap of $6.18B, making BLCO a mid-cap stock based on the current market value shown on Worldtickers.

BLCO's latest stock price on Worldtickers is $17.31. The latest move is $0.10 or 0.61%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

BLCO's quote includes a latest price of $17.31. The market open is $17.29. Previous close is $17.20. The intraday range is $17.16 to $17.45.

BLCO is up in the latest quote, with a move of $0.10 or 0.61%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

BLCO generated $5.32B in trailing revenue. Revenue growth is 9.10%, which helps show whether demand is expanding or slowing.

BLCO's revenue growth is 9.10%, which is a positive demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

No, BLCO does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -$171.00M.

Gross margin is 61.44%. Margins show how efficiently Bausch + Lomb Corporation turns revenue into profit.

Bausch + Lomb Corporation carries $5.11B and holds $367.00M in cash.

BLCO holds $367.00M on its balance sheet.

BLCO's book value per share is $18.09.

Institutions hold 11.15% of BLCO shares. Insiders hold 87.34% of shares. Ownership mix helps investors understand how much of Bausch + Lomb Corporation is held by professional investors and company insiders.

BLCO has 357.17M shares outstanding. Float shares are 45.23M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for BLCO, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for BLCO is $1.09. Revenue growth is 9.10%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

BLCO's trailing EPS is -$0.48. Forward EPS is $1.09. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

BLCO is in the Healthcare sector. Its earnings multiple is 15.83x. Its latest displayed growth metric is 9.10%. Compare these figures with sector peers before deciding whether Bausch + Lomb Corporation is stronger or weaker than average.

BLCO trades at $17.31. The stock trades at 15.83x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Bausch + Lomb Corporation's fundamentals.

BLCO risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.55, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

BLCO should be compared with companies in Medical Instruments & Supplies. Its earnings multiple is 15.83x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Bausch + Lomb Corporation (BLCO) operates in Healthcare, specifically Medical Instruments & Supplies. Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide o

BLCO trades on NYSE. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

BLCO stock is priced in USD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Bausch + Lomb Corporation's official website listed on Worldtickers is www.bausch.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Bausch + Lomb Corporation employs about 13K people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Bausch + Lomb Corporation is headquartered in Vaughan, ON, Canada. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

BLCO is in the Healthcare sector and the Medical Instruments & Supplies industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

BLCO has traded between $13.77 and $18.92 over the past 52 weeks. At $17.31, it is 8.51% below the high and 25.72% above the low. The 52-week range helps gauge long-term price momentum.

BLCO is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is $16.34 and its 200-day moving average is $16.46.

BLCO's RSI is 60.71. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

BLCO's latest RSI reading is 60.71, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for BLCO is near $15.64. Key resistance is near $17.77. Breaks above resistance or below support can change the short-term technical setup.

BLCO's nearest reported support level is $15.64. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

BLCO's nearest reported resistance level is $17.77. A breakout above resistance can improve momentum, especially when volume confirms the move.

BLCO trades about 423.11K shares daily on average. The latest displayed volume is 104.18K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

BLCO's MACD is 0.04, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

BLCO is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 60.71 (neutral). MACD is bullish. Nearest support is around $15.64. Resistance is around $17.77. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is $16.84 (2.76% from price). MA50 is $16.34 (5.89% from price). MA200 is $16.46 (5.14% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. BLCO's MA20 is $16.84. MA50 is $16.34. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

BLCO's pivot is near $17.24. Support is near $15.64. Resistance is near $17.77. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for BLCO is near $16.77. The next upper resistance zone is near $17.73. These levels help define risk and possible follow-through zones after a breakout or breakdown.

BLCO's Bollinger range is roughly $16.22 to $17.46. Band width is near 7.40%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

BLCO's ATR-based typical daily range is about 2.78%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 104.18K shares. Average volume is about 423.11K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

BLCO's all-time high shown on Worldtickers is $21.95. Its all-time low is $10.45. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

BLCO has a beta of 0.55, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.